Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-20
1998-10-27
Fay, Zohrem
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, A61K 3700
Patent
active
058278184
ABSTRACT:
The invention relates to a pharmaceutical agent which is suitable for subcutaneous injection of protein C, wherein it comprises protein C and a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5279956 (1994-01-01), Griffin et al.
patent: 5358932 (1994-10-01), Foster et al.
Embase Abstract 93038768 (1992). Samama et al.
Okajima et al., Thrombosis and Haemostatis 63(1): 48-53 (1990).
Gruber et al. Blood 73(3): 639-642 (Feb. 15, 1989).
Taylor et al., J. Clin. Invest., 79: 918-925 (Mar. 1987).
Reynolds Martindale, The Extra Pharmacopoeia, pp. 647-648 (1993).
Yan et al. Prespectives in Drug Discovery & Design, 1: 503-520 (1993).
Schwarz et al. Advances in Applied Biotechnology Series 2: 83-89 (1990).
Mitchell et al. Pediatric Research 37(4), Abstract 916, p. 163A (Apr. 1995).
Samama et al. Jeur. 5: 213-217 (1992) (abstract already of record).
Eibl Johann
Schwarz Hans-Peter
Fay Zohrem
Immuno Aktiengesellschaft
LandOfFree
Agent for subcutaneous administration of protein C does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for subcutaneous administration of protein C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for subcutaneous administration of protein C will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1613848